Daily Bulletin

The Times Real Estate

.

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

How to Estimate the Right Skip Bin Size for Your Renovation Project

One of the most challenging aspects of planning a renovation project is estimating the amount of waste you'll generate. Choosing a skip bin that's too small means paying for additional bins or picku...

Daily Bulletin - avatar Daily Bulletin

Cool Room Hire: The Ultimate Solution for Temperature-Sensitive Storage

Businesses in the food, pharmaceutical, and event industries often require reliable refrigeration to keep products fresh and safe. Cool room hire provides a flexible and cost-effective solution for ...

Daily Bulletin - avatar Daily Bulletin

Thryv Australia named global winner of the 2025 Microsoft Advertising Partner Awards

Melbourne – 11 March 2025:   Thryv® (NASDAQ: THRY), provider of the leading small business marketing and sales software platform, has been named the global winner of the Microsoft Advertising Part...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals